Essays /

Cancer Research Essay

Essay preview

page 40

Lab Times



Analysis 1998-2009

Cancer Research
Germany and England form the head-to-head lead in
European cancer research, a discipline which is widely
diverse and, therefore, attracts enormous amounts of citations.


ot long ago, a certain Professor Emeritus was asked what
exactly had been achieved by the enormous input and effort that had gone into cancer research in the last decades. Of course, the inquirer alluded to the fact that up until that day really satisfactory, not to say successful, cancer treatments were, nevertheless, still far out of reach. The old professor, however, just smiled and replied, “Everything we can do today in biomedical research we can do largely due to cancer research. All those wonderful techniques as well as all those fantastic fundamental insights into cell and molecular biology, immunology, virology and many other biomedical fields – do you think we would have really ‘made’ them within the same short time if we hadn’t put so much money, brains and fingers into the ‘battle against cancer’? No way at all! Thus, there has already been a tremendous lot of achievement due to the decade-long commitment to cancer research – even if we are still waiting for really potent cancer cures.” The global fight against the widely perceived “disease no. 1” as the main catalyst for basic research in a whole number of biomedical disciplines, so to speak. Without doubt, there’s some truth about this notion, which is also reflected by the fact that, vice versa, many researchers in their different biomedical fields still maintain some more or less close ties to the various aspects of cancer with their projects. (Even if evil tongues might now insist that the main motivation for this is based on presumably better funding opportunities for “cancer-related” research).

Creeping branches
Be it as it may, clear fact is that one can actually see quite a number of branches from various disciplines creeping from all sides under the gigantic roof of “cancer research”: oncology and haematology, certainly, but also pathology, molecular and cell biology, biochemistry, immunology, radiology, epidemiology, toxicology... The consequence being that you will inevitably encounter a couple of problems when performing a publication analysis of “cancer researchers”. While there is hardly any trouble with comparing the publication outputs of whole countries in cancer

scanning electron
microscope (SEM) image
of prostate cancer cells
(MIT Boston)

research (tables, next page), the analogous comparison of individual researchers is yet another story (table, page 42). The reason being that publication and citation culture as well as the requir...

Read more


-108 -2009 -2012 -54 -9 -96 ./art ./oncol 008 026 030 032 041 084 1 10 100 105 11 11.6 11.7 114 115 118 12 12.0 12.8 126 13 13.8 132 137 138 14 14.3 14.9 144 145 146 15 152 154 155 16 16.2 16.8 160 161 163 165 17 17.1 17.3 17.5 17.8 170 171 18 180 182 184 185 187 188 189 19 19.0 19.4 190 191 194 198 1998 1999 2 20 20.2 20.6 20.8 2002 2005 2009 2010 2011 204 206 21 21.2 21.4 21.5 21.7 217 22 22.4 223 23 238 239 24 241 244 25 253 26 26.4 265 267 27 270 272 28 283 285 286 29 2nd 3 30 304 31 316 32 326 33 330 334 336 337 34 347 352 358 38 383 386 389 39 3rd 4 40 41 411 417 42 427 432 434 436 438 439 440 460 461 470 473 475 489 493 496 4th 5 5.5 506 509 51 531 539 542 55 569 570 572 576 586 593 5th 6 601 623 626 63 632 639 642 649 652 661 677 684 6892 695 7 74 750 759 768 775 778 779 78 8 803 812 814 859 861 87 870 875 885 9 9.3 91 913 922 926 94 941 947 949 95 950 970 980 987 99 absolut accur achiev actual address adjuv adrian agci ago ahead alberto alitalo allud almost alreadi also altogeth among amount amsterdam analog analys analysi andrea anim anoth appear appl apr aron artat articl ask aspect attract australia austria author automat averag away b barcelona bartek base baselga basic battl baumert bear beat behind belgium believ bellvitg bent bernard better bignel biochemist biochemistri biol biolog biologist biom biomed biotechnol blood bosch boston braf brain branch bray breast c ca ca-a calcul cambridg came canada canc cancer cancer-rel cancer-relev cardiovascular carlo case catalyst categori caus cell certain cervic china chris cit citat cite cjlm clear clever clin clinic clinician close cnrs coll colleagu colour colour-enhanc commit compar comparison concomit consequ constitut contrari control copenhagen correspond could count countri coupl cours cox creep ctr cultur cure czech d danish databas davi day de death dec decad decade-long decemb dedic den denmark dep deriv despit development diabet differ direct disciplin diseas distanc divers dm doesn doubt dougla dowsett due easton ecolog effect effort electron embo emerg emeritus encount england english enhanc enorm epidem epidemiol epidemiolog epidemiologist erasmus establish estel et eu eur europ european even everyth evil exact exampl exclus expert explanatori express extract f face fact fantast far ferlay field fight figur final finger finland first fit focuss follow form format former fp7 franc franceschi friend friess fund fundament futreal fx g g.m gave gene gene-express genet genotox german germani gigant giusepp given glioblastoma global go goldhirsch goldman gone gr greec growth grp guido gurdon gustav h hadn haematol haematolog haematologist hamburg han hand hard harri head head-to-head heart hebron heidelberg helmut help helsinki hematol henc high higher hinxton ho hochhaus hosp howev hubrecht human humanita hypoxiainduc icl imag immedi immunolog immunologist imperi implic includ indic individu inevit input inquir insight insist inst instanc instead int interest interv invas ireland israel itali italian italy-bas j j.l.m jaap jackson jacob jan japan jena jiri jmm john josef josé journal jun kari klijn known korea kouzarid krammer kroemer l la lab lancet larg larger last latter lead leader least leav left less level like limit list lj logic london long lot lower lung lyon m made main maintain make manel mani mano mantovani mar mar-apr mario mason mass maxwel may mean mechan med medicin meijer member mention michael microscop might milan mind mit mitch mj mm mol molecular money most-cit mostcit motiv mr much multidisciplinari munich munoz mutat mv n nation natur necessari necessarili negri netherland network neumann nevertheless new next nice norway nose notion nuffield number obtain obvious occupi old omit oncol oncolog oncologist one opportun orang organis osteoporosi ot output overal oxford p pa page paper papillomavirus parasitolog parkin part pathogenesi pathol patholog pathologist pathway pelicci penning peopl per perceiv perform perhap period peter peto pharmacol pictur pier pisani place plus poland pop possibl potent predictor present presum problem process produc product professor profound progr programm project promin prostat provid public publish pure push put qualiti quit r radiolog radiotherapi ralf rank ratcliff rate reach real realis realli reason record reflect relat relev reliabl rep repli repres requir res research respect restrict result reuter richard right risk roof rotterdam roussi rutger ryan sanger satisfactori sauter say scan scienc scotland see self self-explanatori sem sens sep serv sh short side signatur signific silvia simpli slight smile soc solid south spain speak specialist st stand statist stephen still stori stratton stress strong studi stupp subject success suffici sum sure surg surpris survey surviv sweden switzerland tabl take tech techniqu temozolomid term therefor think third thomson three thum thus tie time tip today tongu toni tool top topic total toxicolog toxicologist treatment tremend trial troubl trust truth tumour turkey two typic uk unit univ us usa use usual utrecht valid vall valu van vari varieti various vecchia veer versa verweij vessel vice vienna vijver villejuif virolog virtual vrije vs wait walboom way weatheral web well well-known wellcom went whole wide within without wonder wooster work world worldwid would wp xavier yd year yet